Baton Rouge, LANCT07775924Now EnrollingIRB Ready

Cutaneous Lichen Planus Clinical Trial in Baton Rouge, LA

Access cutting-edge cutaneous lichen planus treatment through this phase 2 clinical trial at a research site in Baton Rouge. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Baton Rouge location

Preparing your pre-screening questions…

Expert Care in Baton Rouge

Access cutaneous lichen planus specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cutaneous lichen planus treatment provided free

Apply for This Baton Rouge Location

Check if you qualify for this cutaneous lichen planus clinical trial in Baton Rouge, LA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baton Rouge

    Convenient for LA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baton Rouge site if eligible
  4. 4Begin participation

About This Cutaneous Lichen Planus Study in Baton Rouge

This study will evaluate the safety and efficacy of GIA632 in participants with moderate to severe cutaneous lichen planus (cLP).

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Male or female (as assigned at birth) participants ≥ 18 years of age at the time of screening.
Individuals with a diagnosis of cLP, confirmed
histologically by a skin biopsy (either historically within 1 year prior to screening or at screening if historical one not available), and
by physical examination by the investigator at screening.
Moderate to severe cLP
Two or more body regions affected (any two or more of the following: head and neck, trunk, upper extremities including hands, lower extremities including feet).
Diagnosis of cLP inadequately controlled by at least one topical treatment for at least 3 months (either via continuous use or burst and taper regimen), or such treatment being considered not advisable, as per investigator judgement, assessed at screening. Topical treatment includes, but is not limited to, topical corticosteroids, topical calcineurin inhibitors, topical cholecalciferol analogues, topical PDE4 inhibitors, topical JAK inhibitors, and topical aryl hydrocarbon receptor agonists. Key

Exclusion Criteria

Individuals unable or unwilling to follow the study procedures, handle the electronic diary (eDiary), and/or to complete the study-related questionnaires.
Diagnosis of drug-induced lichen planus (lichenoid drug eruption) or lichen planus pigmentosus.
Presence of skin conditions that may interfere with study assessments, including histologic findings in the biopsy, as assessed at screening and baseline.
Previous exposure to biologic drugs directly targeting IL-15 or any subunit of the IL-15 receptor.
Use of prohibited medication and treatments. Other protocol-defined inclusion/exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baton Rouge?

Yes, this clinical trial (NCT07775924) has an active research site in Baton Rouge, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cutaneous Lichen Planus Treatment Options in Baton Rouge, LA

If you're searching for cutaneous lichen planus treatment options in Baton Rouge, LA, this clinical trial (NCT07775924) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baton Rouge research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced cutaneous lichen planus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cutaneous lichen planus clinical trials near you to find additional studies recruiting in your area.

More Interstitial Cystitis Trials in Baton Rouge, LA

See all interstitial cystitis clinical trials recruiting in Baton Rouge — not just this study.

Browse Interstitial Cystitis Trials in Baton Rouge →

Browse More Trials by Condition

Interstitial Cystitis TrialsLichen Planus TrialsAll Conditions →

Ready to Join in Baton Rouge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baton Rouge, LA